Zero Gravity Solutions (ZGSI) 10-Q 12 Aug 16 2016 Q2 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
	Jun. 30, 2016	Aug. 02, 2016
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2016
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	Q2
Entity Registrant Name	Zero Gravity Solutions, Inc.
Entity Central Index Key	1,574,186
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Trading Symbol	ZGSI
Entity Common Stock, Shares Outstanding		38,751,597

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Jun. 30, 2016	Dec. 31, 2015
CURRENT ASSETS
Cash	$ 2,100,998	$ 2,851,118
Accounts receivable, trade	48,979	44,877
Accounts receivable, other	25,350	0
Prepaid compensation	0	97,330
Prepaid expenses	303,676	198,416
Inventory	29,774	21,934
Total current assets	2,508,777	3,213,675
Property and equipment - net	91,489	51,736
OTHER ASSETS
Deposit	3,417	6,534
Prepaid royalties - related parties	220,010	193,282
TOTAL ASSETS	2,823,693	3,465,227
CURRENT LIABILITIES
Accounts payable	262,832	66,945
Accounts payable- related party	85,625	90,000
Deferred compensation, related party	12,500	12,500
Notes payable	66,769	142,756
Total current liabilities	427,726	312,201
LONG TERM LIABILITIES
Notes payable - related party, net of discount of $9,339 and $122,631, respectively	490,661	377,369
Total long-term liabilities	490,661	377,369
Commitments
Total liabilities	918,387	689,570
STOCKHOLDERS' EQUITY
Common stock; 100,000,000 shares authorized, at $0.001 par value, 38,751,597 and 37,357,597 shares issued and outstanding, respectively	38,752	37,358
Additional paid-in capital	16,385,134	12,129,502
Accumulated deficit	(14,518,580)	(9,391,203)
Total stockholders' equity	1,905,306	2,775,657
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)	$ 2,823,693	$ 3,465,227

Consolidated Balance Sheets _Pa

Consolidated Balance Sheets [Parenthetical] - USD ($)	Jun. 30, 2016	Dec. 31, 2015
Debt Instrument, Unamortized Discount	$ 9,339	$ 122,631
Notes Payable, Related Parties	$ 9,339	$ 122,631
Common Stock, Shares Authorized	100,000,000	100,000,000
Common Stock, Par or Stated Value Per Share (in dollars per share)	$ 0.001	$ 0.001
Common Stock, Shares, Issued	38,751,597	37,357,597
Common Stock, Shares, Outstanding	38,751,597	37,357,597

Consolidated Statements of Oper

Consolidated Statements of Operations and Other Comprehensive Loss - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
REVENUE
Sale of Goods	$ 14,614	$ 82,965	$ 20,314	$ 82,965
Total Revenue	14,614	82,965	20,314	82,965
COST OF REVENUE
Cost of Goods Sold	2,202	7,583	2,648	7,583
Royalty Expense (related party)	732	4,265	1,017	4,265
Total Cost of Revenue	2,934	11,848	3,665	11,848
GROSS PROFIT	11,680	71,117	16,649	71,117
OPERATING EXPENSES
General and administrative	2,088,536	1,375,222	4,793,815	2,467,364
Research and development	106,380	4,816	214,165	12,916
Total operating expenses	2,194,916	1,380,038	5,007,980	2,480,280
LOSS FROM OPERATIONS	(2,183,236)	(1,308,921)	(4,991,331)	(2,409,163)
OTHER EXPENSES
Other income	356	0	2,070	0
Interest expense (related party)	(12,086)	(1,282)	(24,824)	(2,565)
Accretion of debt discount (related party)	(56,659)	0	(113,292)	0
Total other income (expenses)	(68,389)	(1,282)	(136,046)	(2,565)
NET LOSS	$ (2,251,625)	$ (1,310,203)	$ (5,127,377)	$ (2,411,728)
NET LOSS PER SHARE - BASIC AND DILUTED	$ (0.06)	$ (0.04)	$ (0.13)	$ (0.07)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC AND DILUTED	38,734,410	33,592,291	38,366,762	33,037,091
OTHER COMPREHENSIVE LOSS
Net loss	$ (2,251,625)	$ (1,310,203)	$ (5,127,377)	$ (2,411,728)
Foreign currency translation loss	0	(379)	0	(7,939)
COMPREHENSIVE LOSS	$ (2,251,625)	$ (1,310,582)	$ (5,127,377)	$ (2,419,667)

Condensed Consolidated Statemen

Condensed Consolidated Statements of Cash Flows - USD ($)	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (5,127,377)	$ (2,411,728)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	6,638	3,349
Common stock issued for services	25,000	452,000
Warrants issued for services	11,899	723,695
Stock options issued as compensation	2,654,126	0
Amortization of debt issuance costs	113,292	0
Changes in operating assets and liabilities:
Account receivable, trade	(4,102)	975
Accounts receivable, other	(25,350)
Prepaid expenses	(105,260)	(231,946)
Prepaid compensation	97,330	0
Prepaid royalties - related parties	(26,728)	(52,013)
Inventory	(7,840)	(6,802)
Deposit	3,117	(400)
Accounts payable	195,887	210,928
Accounts payable - related party	(4,375)	0
Net cash used in operating activities	(2,193,743)	(1,311,941)
CASH FLOWS FROM INVESTING ACTIVITIES
Cash paid to purchase equipment	(46,391)	(15,582)
Net cash used in investing activities	(46,391)	(15,582)
CASH FLOWS FROM FINANCING ACTIVITIES
Payments of notes payable	(75,986)	(69,775)
Repayment on notes payable - related party	0	(11,000)
Proceeds from sale of common stock	1,717,500	1,278,500
Payment of offering costs	(151,500)	(95,500)
Net cash provided by financing activities	1,490,014	1,102,225
EFFECT OF EXCHANGE RATES ON CASH	0	(7,939)
NET (DECREASE) INCREASE IN CASH	(750,120)	(233,237)
CASH AT BEGINNING OF PERIOD	2,851,118	253,677
CASH AT END OF PERIOD	2,100,998	20,440
CASH PAID FOR:
Interest	12,086	0
Income Taxes	0	0
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Warrants issued as direct offering costs	$ 181,537	$ 185,103

ORGANIZATION, AND SUMMARY OF SI

ORGANIZATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	Jun. 30, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]	Zero Gravity Solutions, Inc. (the “Company”) is a biotechnology company focused on commercializing scientific breakthroughs in the area of patentable stem cell technologies designed for and derived from multiple experiments on the International Space Station (“ISS”). These technologies are focused on improving world agriculture by providing valuable solutions to challenges facing humanity. The Company is currently focused on a cost effective, ionic nutrient delivery system for plants that can delivery minerals and micronutrients systemically at the cellular level of a plant (BAM-FX™) and the production and alteration of new varieties of novel stem cells with unique and beneficial characteristics in the prolonged zero/micro gravity environment (Directed Selection). The Company owns proprietary technology for its first commercial product, BAM-FX™ that can boost nutritional value and enhance the immune system of food crops without the use of genetic modification. The Company was organized on August 19, 1983 Going Concern and Management Plans The Company has experienced recurring losses and negative cash flows from operations. At June 30, 2016, the Company had approximate cash balances of $ 2,101,000 2,081,000 1,905,000 14,519,000 These factors raise doubt about its ability to continue as a going concern. Management’s strategic plans include the following: - continuing to advance development and sale of the Company’s principal product, BAM-FX™; - pursuing additional capital raising opportunities; and - continuing to develop prospective partnering or distribution opportunities. Certain information or footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been omitted, pursuant to the rules and regulations of the Securities and Exchange Commission for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows. It is management's opinion, however, that all material adjustments (consisting of normal recurring adjustments) have been made which are necessary for a fair financial statement presentation. The interim results for the period ended June 30, 2016, are not necessarily indicative of results for the full fiscal year. These unaudited financial statements should be read in conjunction with the audited financial statements and the notes thereto for the year ended December 31, 2015. For the purposes of the statement of cash flows, the Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company had no cash equivalents at June 30, 2016 and December 31, 2015. The accompanying unaudited interim consolidated financial statements include the accounts of Zero Gravity Solutions, Inc. and its subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. June 30, December 31, 2016 2015 Raw materials $ 5,510 $ 8,163 Finished product 13,662 13,771 Consignment Inventory 10,602 - Total Inventory $ 29,774 $ 21,934 Property and equipment is stated at cost, less accumulated depreciation. Expenditures for maintenance and repairs are charged to expense as incurred. Depreciation is computed on a straight-line basis over estimated useful lives. Property and equipment is reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. There were no impairment charges taken during the six months ended June 30, 2016 and 2015. The Company at June 30, 2016 maintained its cash balance with two major national financial institutions. The bank balance at June 30, 2016 exceeded the FDIC limits by $ 132,205 The Company accounts for financial instruments under Financial Accounting Standards Board (FASB) Accounting Standards Codification Topic (ASC) 820, Fair Value Measurements Level 1 — quoted prices (unadjusted) in active markets for identical assets or liabilities; Level 2 — observable inputs other than Level 1, quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, and model-derived prices whose inputs are observable or whose significant value drivers are observable; and Level 3 — assets and liabilities whose significant value drivers are unobservable. Observable inputs are based on market data obtained from independent sources, while unobservable inputs are based on the Company’s market assumptions. Unobservable inputs require significant management judgment or estimation. In some cases, the inputs used to measure an asset or liability may fall into different levels of the fair value hierarchy. In those instances, the fair value measurement is required to be classified using the lowest level of input that is significant to the fair value measurement. Such determination requires significant management judgment. There were no financial assets or liabilities measured at fair value, with the exception of cash (Level 1) as of June 30, 2016 and December 31, 2015. The carrying amounts of the Company’s accounts receivable and accounts payable approximate fair value due to the relatively short period to maturity for these instruments. The carrying value of the Company’s notes payable approximates fair value due to its short period to maturity and its stated interest rates, combined with historic interest rate levels. The carrying value of the Company’s accounts payable and notes payable related party are not practical to estimate due to the related party nature of the underlying transaction. Revenue is recognized when the following four basic criteria have been met: (i) persuasive evidence of an arrangement exists; (ii) delivery has occurred and risk of loss has passed; (iii) the seller's price to the buyer is fixed or determinable; and (iv) collectability is reasonably assured. Revenues are recorded less a reserve for estimated product returns and allowances, which to date has not been significant. Determination of the reserve for estimated product returns and allowances is based on management's analyses and judgments regarding certain conditions. Should future changes in conditions prove management's conclusions and judgments on previous analyses to be incorrect, revenue recognized for any reporting period could be adversely affected. At June 30, 2016, two customers accounted for 89.9 72.9 13.9 73.1 32.8 16.4 14.5 9.4 100 72.9 The Company extends credit to customers generally without requiring collateral. The Company monitors its exposure for credit losses and maintains allowances for anticipated losses. The Company records an allowance for doubtful accounts when it is probable that the accounts receivable balance will not be collected. When estimating the allowance, the Company takes into consideration such factors as its day-to-day knowledge of the financial position of specific clients, the industry and size of its clients. No allowance for doubtful accounts was recorded at June 30, 2016 or December 31, 2015. The Company recognizes the cost of employee services received in exchange for an award of equity instruments in the financial statements and is measured based on the grant date fair value of the award. Stock based compensation expense is recognized over the period during which an employee is required to provide service in exchange for the award (generally the vesting period). The Company estimates the fair value of each stock award at the grant date by using the Black-Scholes option pricing model. Costs equal to these fair values are recognized ratably over the requisite service period based on the number of awards that are expected to vest, or in the period of grant for awards that vest immediately and have no future service condition. For awards that vest over time, cumulative adjustments in later periods are recorded to the extent actual forfeitures differ from our initial estimates: previously recognized compensation cost is reversed if the service or performance conditions are not satisfied and the award is forfeited. The expense resulting from share-based payments is recorded in general and administrative expense. Loss per share is calculated by dividing the Company’s net loss applicable to common shareholders by the weighted average number of common shares outstanding during the period. Diluted loss per share is calculated by dividing the Company’s net income available to common shareholders by the diluted weighted average number of shares outstanding during the period. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. The effect of the inclusion of the dilutive shares would have resulted in a decrease in loss per share. Accordingly, the weighted average shares outstanding have not been adjusted for dilutive shares. Outstanding warrants and stock options are not considered in the calculation as the impact of the potential common shares (totaling approximately 12,258,000 Research and development costs are charged to expenses as incurred. The unaudited interim consolidated financial statements are presented in United States Dollars. As of June 30, 2015, the Company had a bank account in a foreign currency. The balance of this bank account was translated from its local currency (British Pounds) into the reporting currency, U.S. dollars, using period end exchange rates. The resulting translation adjustments were recorded as a separate component of accumulated other comprehensive loss. Revenues and expenses were translated using the weighted average exchange rate for the period. As of June 30, 2016, no such account existed. Transaction gains and losses resulting from foreign currency transactions were immaterial and recorded as foreign exchange gains or losses in the consolidated statement of operations. The Company did not enter into any financial instruments to offset the impact of foreign currency fluctuations. During 2015, upon the termination of the United Kingdom subsidiary, the Company transferred the remaining balance of accumulated other comprehensive loss to operations. No balance exists at June 30, 2016. The Company accounts for income taxes under the asset and liability method, in which deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes the enactment date. A valuation allowance is required to the extent any deferred tax assets may not be realizable. The Company does not have an accrual for uncertain tax positions as of June 30, 2016 and December 31, 2015. The Company files corporate income tax returns with the Internal Revenue Service and the states where the Company determines it is required to do so. The Company’s policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. At June 30, 2016, the Company did not have any accrued interest or penalties associated with any unrecognized tax benefits, nor was any interest expense recognized during the six months ended June 30, 2016 or 2015. Certain reclassifications have been made to prior year information to conform with the current year presentation. The Company continually assesses any new accounting pronouncements to determine their applicability. When it is determined that a new accounting pronouncement affects the Company's financial reporting, the Company undertakes a study to determine the consequences of the change to its consolidated financial statements and assures that there are proper controls in place to ascertain that the Company's consolidated financial statements properly reflect the change. In May 2014, FASB issued Accounting Standards Update ("ASU") No. 2014-09 Revenue from Contracts from Customers In August 2014, the FASB issued ASU No. 2014-15, Presentation of Financial Statements – Going Concern:

PROPERTY AND EQUIPMENT

PROPERTY AND EQUIPMENT	6 Months Ended
	Jun. 30, 2016
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	NOTE 2 – PROPERTY AND EQUIPMENT As of June 30, 2016 December 31, 2015 Computer Equipment $ 15,332 $ 7,082 Equipment and Furniture 74,529 53,944 Leasehold Improvements 17,557 - Accumulated Depreciation (15,929) (9,290) Property and Equipment - Net $ 91,489 $ 51,736

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	6 Months Ended
	Jun. 30, 2016
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	NOTE 3 – RELATED PARTY TRANSACTIONS Notes Payable In July 2015, a director advanced the Company $ 500,000 8.5 350,000 2 416,618 0 184.2 1.66 5 227,258 113,292 Royalty Agreement In 2013, the Company entered into a royalty agreement, which was amended in 2015, with a key employee and principal stockholder of the Company and a current director of the Company. The agreement has a term of 25 5 2,500 Sales subject to the royalty agreement were $ 20,314 82,965 220,010 193,282 prepaid royalties Consulting Agreement During March 2015, the Company entered into a consulting agreement with a director. The agreement had a term of 6 200,000 121,858 75,000 90,000

COMMITMENTS

COMMITMENTS	6 Months Ended
	Jun. 30, 2016
Commitments and Contingencies Disclosure [Abstract]
Commitments Disclosure [Text Block]	NOTE 4 – COMMITMENTS Lease Commitments The Company leases its offices and building space under short term leases. These leases are renewable either monthly or annually. Lease expense was $ 19,097 25,478 37,433 43,193 Research Commitment In January 2016, the Company entered into a Reimbursable Space Act Agreement (the “SAA”) with the National Aeronautics and Space Administration Ames Research Center (“NASA ARC”). Pursuant to the SAA, NASA ARC will evaluate the Company’s nutrient delivery system for commercial agriculture and NASA applications and the potential development of new agricultural technologies and products. The Company provides funding and reimbursement for the costs incurred by NASA ARC under the SAA, but owns any resulting intellectual property created pursuant to the SAA. The Company paid NASA ARC a total of $ 373,750 As of June 30, 2016 $155,750 has been recorded in R & D expense and approximately $218,000 is recorded in prepaid expense. The remainder of the prepaid expense is expected to be charged to R & D expense by the end of 2016.

NOTES PAYABLE

NOTES PAYABLE	6 Months Ended
	Jun. 30, 2016
Debt Disclosure [Abstract]
Debt Disclosure [Text Block]	NOTE 5 – NOTES PAYABLE The Company has two outstanding notes payable utilized for financing corporate insurance premiums. The total outstanding was $66,769 and $142,756 as of June 30, 2016 and December 31,2015 respectively. Both notes carry a rate of interest of 8

EQUITY

EQUITY	6 Months Ended
	Jun. 30, 2016
Equity [Abstract]
Shareholders' Equity and Share-based Payments [Text Block]	NOTE 6 – EQUITY Common Stock Private placement offerings During the six months ended June 30, 2016, the Company issued 1,374,000 1,374,000 2.00 per share 1.25 ross proceeds 1,717,500 151,500 152,575 shares of stock 2.00 Common stock issued for services During the six months ended June 30, 2016, the Company issued for services, 20,000 25,000 During the six months ended June 30, 2015, the Company issued for services, 351,000 452,000 Warrants Warrants issued for services During the six months ended June 30, 2016, the Company issued fully vested, non-forfeitable warrants to purchase 10,000 shares of 2.00 rendered 11,899 0 184.2 1.38 5 During the six months ended June 30, 2015, the Company issued fully vested, non-forfeitable warrants to purchase 631,000 shares of 0.50 195,500 of common stock 3.00 rendered 723,695 0 157.54 1.29 1.69 5 Warrants issued with debt – related party During July 2015 the Company entered into a note payable with a related party. In connection with the note the Company issued warrants to purchase 350,000 2.00 The following is a summary of the Company’s warrant activity for the six months ended June 30, 2016: Weighted Remaining Weighted Average Contractual Aggregate Number of Warrants Exercise Price (in Years) Value Outstanding – January 1, 2016 8,117,075 $ 1.41 Granted 1,536,575 2.00 Exercised Cancelled/Forfeited Outstanding and exercisable - June 30, 2016 9,653,650 $ 1.53 3.7 $ 1,621,989 The aggregate intrinsic value in the table above represents the total intrinsic value (the difference between the estimated stock price on June 30, 2016 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the warrant holders, had all warrant holders been able to, and in fact had, exercised their warrants on June 30, 2016. Stock incentive plan options During November 2015, the Company adopted its 2015 Equity Incentive Plan. The Plan provides stock based compensation to employees, directors and consultants, as more fully described in the Plan. The Company has reserved 4,000,000 under 2,605,000 1,920,000 3,131,958 0 184.2 1.14 1.50 5 Weighted Remaining Weighted Average Contractual Aggregate Number of Options Exercise Price (in Years) Value Outstanding – January 1, 2016 - $ - Granted 2,605,000 1.25 Exercised Cancelled/Forfeited Outstanding - June 30, 2016 2,605,000 $ 1.25 9.6 $ - Excercisable – June 30, 2016 1,920,000 1.25 Nonvested Shares Weighted Average Nonvested Shares Underlying Options Exercise Price Nonvested at January 1, 2016 - $ - Granted 2,605,000 1.25 Vested (1,920,000) 1.25 Cancelled/Forfeited Nonvested at June 30, 2016 685,000 $ 1.25

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	6 Months Ended
	Jun. 30, 2016
Subsequent Events [Abstract]
Subsequent Events [Text Block]	NOTE 7 – SUBSEQUENT EVENTS On July 19, 2016, Michael T. Smith, a member of the Company’s Board of Directors, agreed to an amendment of his promissory note in the principal face amount of $ 500.000 July 16, 2017 1.25 Subsequent to June 30, 2016, 125,000 1.25

ORGANIZATION AND SUMMARY OF SIG

ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
	Jun. 30, 2016
Accounting Policies [Abstract]
Going Concern And Management Plans [Policy Text Block]	Going Concern and Management Plans The Company has experienced recurring losses and negative cash flows from operations. At June 30, 2016, the Company had approximate cash balances of $ 2,101,000 2,081,000 1,905,000 14,519,000 These factors raise doubt about its ability to continue as a going concern. Management’s strategic plans include the following: - continuing to advance development and sale of the Company’s principal product, BAM-FX™; - pursuing additional capital raising opportunities; and - continuing to develop prospective partnering or distribution opportunities.
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation Certain information or footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been omitted, pursuant to the rules and regulations of the Securities and Exchange Commission for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a comprehensive presentation of financial position, results of operations, or cash flows. It is management's opinion, however, that all material adjustments (consisting of normal recurring adjustments) have been made which are necessary for a fair financial statement presentation. The interim results for the period ended June 30, 2016, are not necessarily indicative of results for the full fiscal year. These unaudited financial statements should be read in conjunction with the audited financial statements and the notes thereto for the year ended December 31, 2015.
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and Cash Equivalents For the purposes of the statement of cash flows, the Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company had no cash equivalents at June 30, 2016 and December 31, 2015.
Consolidation, Policy [Policy Text Block]	Principles of Consolidation The accompanying unaudited interim consolidated financial statements include the accounts of Zero Gravity Solutions, Inc. and its subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.
Inventory, Policy [Policy Text Block]	Inventory June 30, December 31, 2016 2015 Raw materials $ 5,510 $ 8,163 Finished product 13,662 13,771 Consignment Inventory 10,602 - Total Inventory $ 29,774 $ 21,934
Property, Plant and Equipment, Policy [Policy Text Block]	Property and Equipment Property and equipment is stated at cost, less accumulated depreciation. Expenditures for maintenance and repairs are charged to expense as incurred. Depreciation is computed on a straight-line basis over estimated useful lives. Property and equipment is reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. There were no impairment charges taken during the six months ended June 30, 2016 and 2015.
Concentration Risk, Credit Risk, Policy [Policy Text Block]	Concentration of Credit Risk The Company at June 30, 2016 maintained its cash balance with two major national financial institutions. The bank balance at June 30, 2016 exceeded the FDIC limits by $ 132,205
Fair Value of Financial Instruments, Policy [Policy Text Block]	Fair Value of Financial Instruments The Company accounts for financial instruments under Financial Accounting Standards Board (FASB) Accounting Standards Codification Topic (ASC) 820, Fair Value Measurements Level 1 — quoted prices (unadjusted) in active markets for identical assets or liabilities; Level 2 — observable inputs other than Level 1, quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, and model-derived prices whose inputs are observable or whose significant value drivers are observable; and Level 3 — assets and liabilities whose significant value drivers are unobservable. Observable inputs are based on market data obtained from independent sources, while unobservable inputs are based on the Company’s market assumptions. Unobservable inputs require significant management judgment or estimation. In some cases, the inputs used to measure an asset or liability may fall into different levels of the fair value hierarchy. In those instances, the fair value measurement is required to be classified using the lowest level of input that is significant to the fair value measurement. Such determination requires significant management judgment. There were no financial assets or liabilities measured at fair value, with the exception of cash (Level 1) as of June 30, 2016 and December 31, 2015. The carrying amounts of the Company’s accounts receivable and accounts payable approximate fair value due to the relatively short period to maturity for these instruments. The carrying value of the Company’s notes payable approximates fair value due to its short period to maturity and its stated interest rates, combined with historic interest rate levels. The carrying value of the Company’s notes payable related party is not practical to estimate due to the related party nature of the underlying transaction.
Revenue Recognition And Accounts Receivable [Policy Text Block]	Revenue Recognition and Accounts Receivable: Revenue is recognized when the following four basic criteria have been met: (i) persuasive evidence of an arrangement exists; (ii) delivery has occurred and risk of loss has passed; (iii) the seller's price to the buyer is fixed or determinable; and (iv) collectability is reasonably assured. Revenues are recorded less a reserve for estimated product returns and allowances, which to date has not been significant. Determination of the reserve for estimated product returns and allowances is based on management's analyses and judgments regarding certain conditions. Should future changes in conditions prove management's conclusions and judgments on previous analyses to be incorrect, revenue recognized for any reporting period could be adversely affected. At June 30, 2016, two customers accounted for 89.9 72.9 13.9 73.1 32.8 16.4 14.5 9.4 100 72.9 The Company extends credit to customers generally without requiring collateral. The Company monitors its exposure for credit losses and maintains allowances for anticipated losses. The Company records an allowance for doubtful accounts when it is probable that the accounts receivable balance will not be collected. When estimating the allowance, the Company takes into consideration such factors as its day-to-day knowledge of the financial position of specific clients, the industry and size of its clients. No allowance for doubtful accounts was recorded at June 30, 2016 or December 31, 2015.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Stock Based Compensation The Company recognizes the cost of employee services received in exchange for an award of equity instruments in the financial statements and is measured based on the grant date fair value of the award. Stock based compensation expense is recognized over the period during which an employee is required to provide service in exchange for the award (generally the vesting period). The Company estimates the fair value of each stock award at the grant date by using the Black-Scholes option pricing model. Costs equal to these fair values are recognized ratably over the requisite service period based on the number of awards that are expected to vest, or in the period of grant for awards that vest immediately and have no future service condition. For awards that vest over time, cumulative adjustments in later periods are recorded to the extent actual forfeitures differ from our initial estimates: previously recognized compensation cost is reversed if the service or performance conditions are not satisfied and the award is forfeited. The expense resulting from share-based payments is recorded in general and administrative expense.
Earnings Per Share, Policy [Policy Text Block]	Loss per Common Share Loss per share is calculated by dividing the Company’s net loss applicable to common shareholders by the weighted average number of common shares outstanding during the period. Diluted loss per share is calculated by dividing the Company’s net income available to common shareholders by the diluted weighted average number of shares outstanding during the period. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. The effect of the inclusion of the dilutive shares would have resulted in a decrease in loss per share. Accordingly, the weighted average shares outstanding have not been adjusted for dilutive shares. Outstanding warrants and stock options are not considered in the calculation as the impact of the potential common shares (totaling approximately 12,258,000
Research and Development Expense, Policy [Policy Text Block]	Research and Development Research and development costs are charged to expenses as incurred.
Foreign Currency Transactions and Translations Policy [Policy Text Block]	Foreign Currency Transactions The unaudited interim consolidated financial statements are presented in United States Dollars. As of June 30, 2015, the Company had a bank account in a foreign currency. The balance of this bank account was translated from its local currency (British Pounds) into the reporting currency, U.S. dollars, using period end exchange rates. The resulting translation adjustments were recorded as a separate component of accumulated other comprehensive loss. Revenues and expenses were translated using the weighted average exchange rate for the period. As of June 30, 2016, no such account existed. Transaction gains and losses resulting from foreign currency transactions were immaterial and recorded as foreign exchange gains or losses in the consolidated statement of operations. The Company did not enter into any financial instruments to offset the impact of foreign currency fluctuations. During 2015, upon the termination of the United Kingdom subsidiary, the Company transferred the remaining balance of accumulated other comprehensive loss to operations. No balance exists at June 30, 2016.
Income Tax, Policy [Policy Text Block]	Income Taxes The Company accounts for income taxes under the asset and liability method, in which deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in operations in the period that includes the enactment date. A valuation allowance is required to the extent any deferred tax assets may not be realizable. The Company does not have an accrual for uncertain tax positions as of June 30, 2016 and December 31, 2015. The Company files corporate income tax returns with the Internal Revenue Service and the states where the Company determines it is required to do so. The Company’s policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. At June 30, 2016, the Company did not have any accrued interest or penalties associated with any unrecognized tax benefits, nor was any interest expense recognized during the six months ended June 30, 2016 or 2015.
Reclassification, Policy [Policy Text Block]	Reclassifications Certain reclassifications have been made to prior year information to conform with the current year presentation.
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Issued Accounting Pronouncements The Company continually assesses any new accounting pronouncements to determine their applicability. When it is determined that a new accounting pronouncement affects the Company's financial reporting, the Company undertakes a study to determine the consequences of the change to its consolidated financial statements and assures that there are proper controls in place to ascertain that the Company's consolidated financial statements properly reflect the change. In May 2014, FASB issued Accounting Standards Update ("ASU") No. 2014-09 Revenue from Contracts from Customers In August 2014, the FASB issued ASU No. 2014-15, Presentation of Financial Statements – Going Concern:

ORGANIZATION AND SUMMARY OF S14

ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	6 Months Ended
	Jun. 30, 2016
Accounting Policies [Abstract]
Schedule of Inventory, Current [Table Text Block]	Inventory is valued on a lower of first-in, first out (FIFO) cost or market basis. Inventory consisted of: June 30, December 31, 2016 2015 Raw materials $ 5,510 $ 8,163 Finished product 13,662 13,771 Consignment Inventory 10,602 - Total Inventory $ 29,774 $ 21,934

PROPERTY AND EQUIPMENT (Tables)

PROPERTY AND EQUIPMENT (Tables)	6 Months Ended
	Jun. 30, 2016
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Table Text Block]	Property and equipment are summarized as follows: As of June 30, 2016 December 31, 2015 Computer Equipment $ 15,332 $ 7,082 Equipment and Furniture 74,529 53,944 Leasehold Improvements 17,557 - Accumulated Depreciation (15,929) (9,290) Property and Equipment - Net $ 91,489 $ 51,736

EQUITY (Tables)

EQUITY (Tables)	6 Months Ended
	Jun. 30, 2016
Class of Stock [Line Items]
Schedule of Nonvested Share Activity [Table Text Block]	Nonvested Shares Weighted Average Nonvested Shares Underlying Options Exercise Price Nonvested at January 1, 2016 - $ - Granted 2,605,000 1.25 Vested (1,920,000) 1.25 Cancelled/Forfeited Nonvested at June 30, 2016 685,000 $ 1.25
Stock Compensation Plan [Member]
Class of Stock [Line Items]
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]	Weighted Remaining Weighted Average Contractual Aggregate Number of Options Exercise Price (in Years) Value Outstanding – January 1, 2016 - $ - Granted 2,605,000 1.25 Exercised Cancelled/Forfeited Outstanding - June 30, 2016 2,605,000 $ 1.25 9.6 $ - Excercisable – June 30, 2016 1,920,000 1.25
Warrant [Member]
Class of Stock [Line Items]
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]	Weighted Remaining Weighted Average Contractual Aggregate Number of Warrants Exercise Price (in Years) Value Outstanding – January 1, 2016 8,117,075 $ 1.41 Granted 1,536,575 2.00 Exercised Cancelled/Forfeited Outstanding and exercisable - June 30, 2016 9,653,650 $ 1.53 3.7 $ 1,621,989

ORGANIZATION AND SUMMARY OF S17

ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	Jun. 30, 2016	Dec. 31, 2015
Raw materials	$ 5,510	$ 8,163
Finished product	13,662	13,771
Consignment Inventory	10,602	0
Total Inventory	$ 29,774	$ 21,934

ORGANIZATION AND SUMMARY OF S18

ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Textual) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2016	Dec. 31, 2015	Jun. 30, 2015	Dec. 31, 2014
Accounting Policies [Line Items]
Weighted Average Number Diluted Shares Outstanding Adjustment	12,258,000
Cash, Uninsured Amount	$ 132,205
Entity Incorporation, Date of Incorporation	Aug. 19, 1983
Working Capital	$ 2,081,000
Cash	2,100,998	$ 2,851,118	$ 20,440	$ 253,677
Stockholders' Equity Attributable to Parent	1,905,306	2,775,657
Retained Earnings (Accumulated Deficit)	$ (14,518,580)	$ (9,391,203)
Accounts Receivable [Member]
Accounting Policies [Line Items]
Concentration Risk, Percentage	89.90%	100.00%
Accounts Receivable [Member] | CHILE
Accounting Policies [Line Items]
Concentration Risk, Percentage	72.90%
Sales [Member]
Accounting Policies [Line Items]
Concentration Risk, Percentage	73.10%
Customer One [Member] | Accounts Receivable [Member]
Accounting Policies [Line Items]
Concentration Risk, Percentage	72.90%
Customer One [Member] | Sales [Member]
Accounting Policies [Line Items]
Concentration Risk, Percentage	32.80%
Customer Two [Member] | Accounts Receivable [Member]
Accounting Policies [Line Items]
Concentration Risk, Percentage	13.90%
Customer Two [Member] | Sales [Member]
Accounting Policies [Line Items]
Concentration Risk, Percentage	16.40%
Customer Three [Member] | Sales [Member]
Accounting Policies [Line Items]
Concentration Risk, Percentage	14.50%
Customer Four [Member] | Sales [Member]
Accounting Policies [Line Items]
Concentration Risk, Percentage	9.40%

PROPERTY AND EQUIPMENT (Details

PROPERTY AND EQUIPMENT (Details) - USD ($)	Jun. 30, 2016	Dec. 31, 2015
Property, Plant and Equipment [Line Items]
Accumulated Depreciation	$ (15,929)	$ (9,290)
Property and Equipment - Net	91,489	51,736
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	15,332	7,082
Equipment and Furniture [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	74,529	53,944
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 17,557	$ 0

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Textual) - USD ($)	1 Months Ended		3 Months Ended		6 Months Ended		12 Months Ended
	Jul. 31, 2015	Mar. 31, 2015	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015	Dec. 31, 2013	Dec. 31, 2015
Related Party Transaction [Line Items]
Debt Instrument, Unamortized Discount			$ 9,339		$ 9,339			$ 122,631
Royalty Expense			732	$ 4,265	1,017	$ 4,265
General and Administrative Expense			2,088,536	$ 1,375,222	4,793,815	2,467,364
Accounts Payable, Related Parties, Current			85,625		85,625			90,000
Royalty Agreements [Member]
Related Party Transaction [Line Items]
Royalty Revenue					20,314	82,965
Deferred Compensation Arrangement with Individual, Maximum Contractual Term							25 years
Royalty Expense							$ 2,500
Advance Royalties, Total			220,010		220,010			$ 193,282
Royalty Agreements [Member] | Sales Revenue, Net [Member]
Related Party Transaction [Line Items]
Concentration Risk, Percentage							5.00%
Fair Value, Measurements, Recurring [Member]
Related Party Transaction [Line Items]
Liabilities, Fair Value Disclosure, Recurring	$ 416,618
Fair Value Assumptions, Expected Dividend Rate	0.00%
Fair Value Assumptions, Expected Volatility Rate	184.20%
Fair Value Assumptions, Risk Free Interest Rate	1.66%
Fair Value Assumptions, Expected Term	5 years
Debt Instrument, Unamortized Discount			$ 227,258		227,258
Other Expenses, Total					$ 113,292
Notes Payable, Other Payables [Member]
Related Party Transaction [Line Items]
Warrants To Purchase Common Stock Shares	350,000
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 2
Director [Member]
Related Party Transaction [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	8.50%
Notes Payable, Total	$ 500,000
Consulting Agreement Term		6 months
Professional Fees		$ 200,000
General and Administrative Expense						$ 121,858

COMMITMENTS (Details Textual)

COMMITMENTS (Details Textual) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015	Dec. 31, 2015
Operating Leased Assets [Line Items]
Operating Leases, Rent Expense, Net, Total	$ 19,097	$ 25,478	$ 37,433	$ 43,193
Research and Development Expense	106,380	$ 4,816	214,165	$ 12,916
Other Prepaid Expense, Current	0		0		$ 97,330
Reimbursable Space Act Agreement [Member]
Operating Leased Assets [Line Items]
Research and Development Expense			373,750
Other Prepaid Expense, Current	$ 218,000		$ 218,000

NOTES PAYABLE (Details Textual)

NOTES PAYABLE (Details Textual) - USD ($)	Jun. 30, 2016	Dec. 31, 2015
Debt Instrument [Line Items]
Notes Payable, Current	$ 66,769	$ 142,756
Notes Payable [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	8.00%

EQUITY (Details)

EQUITY (Details)	6 Months Ended
	Jun. 30, 2016USD ($)$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Warrants, Granted	2,605,000
Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Warrants, Outstanding	8,117,075
Number of Warrants, Granted	1,536,575
Number of Warrants, Outstanding	9,653,650
Weighted Average Exercise Price, Outstanding | $ / shares	$ 1.41
Weighted Average Exercise Price, Granted | $ / shares	2
Weighted Average Exercise Price, Outstanding | $ / shares	$ 1.53
Weighted Average Remaining Contractual Life, Outstanding and exercisable (in years)	3 years 8 months 12 days
Aggregate Intrinsic Value, Outstanding and exercisable | $	$ 1,621,989

EQUITY (Details 1)

EQUITY (Details 1)	6 Months Ended
	Jun. 30, 2016USD ($)$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Warrants, Granted	2,605,000
Number of Warrants, Excercisable	1,920,000
Weighted Average Exercise Price, Exercisable | $ / shares	$ 1.25
Stock Compensation Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Warrants, Outstanding	0
Number of Warrants, Granted	2,605,000
Number of Warrants, Outstanding	2,605,000
Weighted Average Exercise Price, Outstanding | $ / shares	$ 0
Weighted Average Exercise Price, Granted | $ / shares	1.25
Weighted Average Exercise Price, Outstanding | $ / shares	$ 1.25
Weighted Average Remaining Contractual Life, Outstanding and exercisable (in years)	9 years 7 months 6 days
Number of Warrants, Aggregate Intrinsic Value | $	$ 0

EQUITY (Details 2)

EQUITY (Details 2)	6 Months Ended
	Jun. 30, 2016$ / sharesshares
Schedule Of Nonvested Share Activity [Line Items]
Nonvested Shares Underlying Options, Nonvested | shares	0
Nonvested Shares Underlying Options, Granted | shares	2,605,000
Nonvested Shares Underlying Options, Vested | shares	(1,920,000)
Nonvested Shares Underlying Options, Nonvested | shares	685,000
Weighted Average Exercise Price, Nonvested | $ / shares	$ 0
Weighted Average Exercise Price, Granted | $ / shares	1.25
Weighted Average Exercise Price, Vested | $ / shares	1.25
Weighted Average Exercise Price, Nonvested | $ / shares	$ 1.25

EQUITY (Details Textual)

EQUITY (Details Textual) - USD ($)	1 Months Ended		6 Months Ended
	Nov. 30, 2015	Jul. 31, 2015	Jun. 30, 2016	Jun. 30, 2015
Share Based Payment Award, Fair Value Assumption [Line Items]
Payments of Stock Issuance Costs			$ 151,500	$ 95,500
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			2,605,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares			1,920,000
Stock Incentive Plan [Member]
Share Based Payment Award, Fair Value Assumption [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate			184.20%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum			1.14%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum			1.50%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term			5 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value			$ 3,131,958
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments			$ 0
Stock Incentive Plan [Member] | Transaction 2015 [Member]
Share Based Payment Award, Fair Value Assumption [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee	4,000,000
Private Placement Offerings [Member]
Share Based Payment Award, Fair Value Assumption [Line Items]
Share Price			$ 2
Stock Issued During Period, Shares, New Issues			1,374,000
Sale of Stock, Price Per Share			$ 1.25
Warrants To Purchase Common Stock Shares			1,374,000
Issued one [Member] | Transaction 2016 [Member]
Share Based Payment Award, Fair Value Assumption [Line Items]
Stock Issued During Period, Shares, Issued for Services			20,000
Stock Issued During Period, Value, Issued for Services			$ 25,000
Issued Two [Member] | Transaction 2016 [Member]
Share Based Payment Award, Fair Value Assumption [Line Items]
Stock Issued During Period, Shares, Issued for Services				351,000
Stock Issued During Period, Value, Issued for Services				$ 452,000
Common Stock [Member] | Private Placement Offerings [Member]
Share Based Payment Award, Fair Value Assumption [Line Items]
Payments of Stock Issuance Costs			$ 151,500
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 2
Warrants To Purchase Common Stock Shares			152,575
Proceeds from Issuance Initial Public Offering			$ 1,717,500
Common Stock [Member] | Employees and Consultants [Member] | Transaction 2015 [Member]
Share Based Payment Award, Fair Value Assumption [Line Items]
Share Price				$ 3
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period				195,500
Common Stock [Member] | Employees and Consultants2 [Member] | Transaction 2015 [Member]
Share Based Payment Award, Fair Value Assumption [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period				50,000
Class of Warrant or Right, Exercise Price of Warrants or Rights				$ 6
Warrant One [Member] | Employees and Consultants [Member] | Transaction 2016 [Member]
Share Based Payment Award, Fair Value Assumption [Line Items]
Share Price			$ 2
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period			10,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value			$ 11,899
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate			0.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate			184.20%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum			1.38%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term			5 years
Warrant Two [Member] | Employees and Consultants [Member] | Transaction 2015 [Member]
Share Based Payment Award, Fair Value Assumption [Line Items]
Share Price				$ 0.50
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period				631,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value				$ 723,695
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate				0.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate				157.54%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum				1.29%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum				1.69%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term				5 years
Warrants Issued with Debt - Related Party [Member] | Transaction 2016 [Member]
Share Based Payment Award, Fair Value Assumption [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 2
Warrants To Purchase Common Stock Shares		350,000

SUBSEQUENT EVENTS (Details Text

SUBSEQUENT EVENTS (Details Textual) - USD ($)	1 Months Ended
	Jul. 31, 2016	Jul. 19, 2016	Jun. 30, 2016
Subsequent Event [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price			$ 1.25
Subsequent Event [Member]
Subsequent Event [Line Items]
Debt Instrument, Face Amount		$ 500
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period	125,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$ 1.25
Subsequent Event [Member] | Director [Member]
Subsequent Event [Line Items]
Debt Instrument, Maturity Date	Jul. 16, 2017
Debt Instrument, Convertible, Conversion Price		$ 1.25